Bristol-Myers Squibb financials
$63.88+1.62%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.97B | $11.49B | $12.50B | $12.22B | $12.27B | $11.20B | $12.34B | $11.89B | $12.20B | $11.87B | $11.48B | $10.97B |
| Gross profit | $9.25B | $8.07B | $8.40B | $8.79B | $8.90B | $8.17B | $7.53B | $8.94B | $8.93B | $8.93B | $8.73B | $8.46B |
| Gross margin | 71.3% | 70.2% | 67.2% | 71.9% | 72.5% | 72.9% | 61.0% | 75.1% | 73.2% | 75.3% | 76.1% | 77.1% |
| Operating income | $4.03B | $3.27B | $1.42B | $3.01B | $2.27B | $3.31B | $480.0M | $1.91B | $1.56B | -$11.52B | $1.30B | $1.88B |
| Net income | $3.32B | $2.68B | $1.09B | $2.20B | $1.31B | $2.46B | $72.0M | $1.21B | $1.68B | -$11.91B | $1.76B | $1.93B |
| Net margin | 25.6% | 23.3% | 8.7% | 18.0% | 10.7% | 21.9% | 0.6% | 10.2% | 13.8% | −100.4% | 15.4% | 17.6% |
| Diluted EPS | $1.62 | $1.31 | $0.53 | $1.08 | $0.64 | $1.20 | $0.04 | $0.60 | $0.83 | $-5.89 | $0.87 | $0.93 |
| EBITDA | $4.62B | $3.87B | $2.40B | $4.02B | $4.79B | $4.32B | $2.36B | $4.50B | $4.16B | -$8.98B | $1.30B | $4.31B |
| Operating cash flow | $3.39B | $1.10B | $1.97B | $6.31B | $3.92B | $1.95B | $4.44B | $5.59B | $2.33B | $2.83B | $4.25B | $4.75B |
| Free cash flow | $3.09B | $757.0M | $1.60B | $5.99B | $3.56B | $1.69B | $4.06B | $5.27B | $2.06B | $2.55B | $3.92B | $4.41B |
| Diluted shares | 2,048.0M | 2,047.0M | 2,039.0M | 2,039.0M | 2,038.0M | 2,040.0M | 2,025.0M | 2,031.0M | 2,029.0M | 2,023.0M | 2,033.0M | 2,064.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $8.72B | $9.57B | $10.21B | $15.73B | $12.60B | $10.88B |
| Short-term investments | $2.35B | $912.0M | $464.0M | $776.0M | $1.00B | $907.0M |
| Total debt | $43.12B | $44.46B | $45.11B | $48.98B | $49.19B | $49.71B |
| Total assets | $87.63B | $86.48B | $90.04B | $96.89B | $94.68B | $92.43B |
| Total liabilities | $65.31B | $66.37B | $71.53B | $78.29B | $77.19B | $74.98B |
| Shareholders' equity | $22.32B | $20.10B | $18.51B | $18.60B | $17.49B | $17.45B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology